2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinic
a day ago
- #dyslipidemia
- #cardiovascular disease
- #cholesterol management
- The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia replaces the 2018 guideline on blood cholesterol management.
- A comprehensive literature search was conducted from October 2024 to December 2024, covering clinical studies, systematic reviews, and meta-analyses.
- The guideline focuses on the evaluation, management, and monitoring of dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).
- Key areas addressed include primary prevention, risk assessment, and the use of statins and other lipid-lowering agents.